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RELATIONSHIP OF MOLECULAR CONFIGURATION TO THE ACTIVITY OF
FUROCOUMARINS WHICH INCREASE THE CUTANEOUS RESPONSES
FOLLOWING LONG WAVE ULTRAVIOLET RADIATION*
M. A. PATHAK, B.Sc. (ions.), M.Se. (Tech.) AND T. B. FITZPATRICK, M.D., Ph.D.
The furocoumarin group of compounds includes
psoralen, 8-methoxypsoralen (methoxsalen) and
other related compounds. The leaves and fruits
of plants containing naturally occurring furo-
coumarins have been used for centuries in Egypt
(1), India (2), and other oriental countries in the
treatment of skin depigmentation. Methoxsalen
has more recently been used in the treatment of
vitiligo. In addition, Musaj o (3), Fitzpatrick
et at. (4) have reported increased pigmentation
of skin in individuals exposed to sunlight in
presence of this compound. Musajo has also
investigated the relative activity of these com-
pounds when applied topically to human skin.
Fowiks et at. (5) have recently reported the
photosensitizing action of furocoumarin, cou-
mann and several other substances in bacteria
in presence of long wave ultraviolet light
(>3200 A).
The purpose of this investigation was (a) to set
up a bioassay method using mammalian albino
guinea pig skin to study the relative activity of
the compounds, (b) to correlate the erythema-
inducing property of various compounds in terms
of molecular configuration, (c) to determine the
minimum effective concentration of different
compounds on guinea pig skin and correlate these
data with the results obtained with human skin.
It appears that albino guinea pig skin can be
conveniently used for assaying the photodynami-
cally active and the inactive compounds. Using
long wave ultraviolet light of 3200 A and above
wavelength, erythema and pigment inducing
compounds can be given orally or applied topi-
cally and tested for their relative activity. The
parent substance, psoralen, exhibits maximum
activity. The order of activity of other active
compounds appears to he (1) psoralen, (2) 4,5',S-
trimethylpsoralen, (3) 4-methylpsoralen, (4) 5'S-
dimethylpsoralen, (5) 8-methoxypsoralen, (6)
* From the Division of Dermatology, Univer-
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5-methoxypsoralen, (7) 4', 5'-dihydroxanthotoxin
(topically only), (8) psoralen glucoside, (9) 8-iso-
amyleneoxypsoralen. Compounds like isober-
gapten and 4, 5'-dimethylisopsoralen showed
weak activity. The furan ring and coumarin ring
configuration compounds do not show any photo-
activation. The compound to be active photo-
dynamically in inducing erythema and pig-
mentation should have a linearly annulated
fused ring structure of furan and coumarin
ring as present in psoralea molecule. A non-
linear angular structure like isopsoralen mole-
cule does not exhibit any activity. Carbon
atoms 5 and 8, valence bonds between carbons
3-4 and 4'-S', and attachment of furan ring at
carbon 6 and 7 are the active centers in the mole-
cule. An intact lactone ring is essential for the
compound to be active. Methyl substitutions at
carbon atoms 4,5', 8 in psoralen molecule, though,
do not increase the relative activity of the basic
molecule, but still they retain its photodynamic
activity. Methoxy substitution in 8 or 5 position,
however, decreases the activity. Hydroxyl, nitro,
amino group substitution render the compound
inactive. Substituting radicals which increase
the electron density of reactive centers retain the
activity of the molecule, whereas radicals which
decrease the electron density lower the photo-
dynamic activity.
MATERIAL5 AND METHODS
Using albino guinea pig and human skin, condi-
tions and requirements for a bioassay method were
standardized to evaluate the relative activity of
various compounds. The degree of erythema pro-
duced in presence of a known amount of a sub-
stance and the minimum effective concentration
which produces erythema following topical appli-
cation and oral administration were determined.
On the back of a clean-shaved, smooth skinned
guinea pig, and on the innerside of forearms of
medical students, varying concentrations of each
compound dissolved in 95% ethanol were applied
topically in a number of squares of one inch area
marked on the skin with adhesive tape. For oral ad-
ministration the compound was given in the form
of capsules. In topical studies with guinea pig and
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human skin, a lag period of 30 to 45 minutes after
applying the compound was observed to give
optimum response of erytbema. In oral studies
with guinea pig, a lag period of 1'/2 hours after
feeding the compound was required before the
animals could be subjected to radiation. With
guinea pigs, a total time of 45 minutes' exposure
was found to give optimum response, whereas on
human skin 15 minutes' exposure was observed to
be adequate.
Ultraviolet light lamp (G. E. Wood's light
model no. 70) emitting light of wavelengths above
3200 A (which had 52%, 25%, 35% and less than
1% transmission at 3650 A, 3400 A, 3800 A and
3200 A respectively) was used as a source of radia-
tion. A distance of 14 cm. was kept constant
between the lamp and the radiated skin area.
The degree of erythema which developed at the
end of 18 and 36 hours after radiation was em-
ployed as a measure of relative activity of the
compound. Erythema grading was evaluated
photometrically (Photoelectric reflection meter
model 610, Photovolt Corporation, New York)
and compared with the visible intensity which
was recorded in terms of conventional + or —
signs.
In all these studies, care was taken to avoid
exposure of skin directly to fluorescent light or
sunlight before and after radiation.
EESULTS
Using albino guinea pig and human skin, the
relative activity of various furocoumarins, cou-
marins and other related compounds has been
investigated and a relationship of molecular con-
figuration to the activity of these compounds
postulated. In Table I, the relative activity of
furocoumarins has been briefly summarized and
expressed in graded response of + or — signs for
topical as well as oral studies. The relative ac-
tivity has been expressed after comparing the
crythema response as observed by visible in-
tensity grading and reflection meter reading.
It can be seen that out of 17 furocoumarin
compounds tested, eleven showed photoactiva-
tion. Six compounds, namely psoralen, 4-methyl-
psoralen, 5', 8-dimethylpsoralen, 4,5', 8-trimeth-
ylpsoralen, 8-methoxypsoralen, 5-methoxypso-
ralen, exhibited more activity than psoralen
glucoside, dihydroxanthotoxin, 8-isoamyleneoxy-
psoralen, dimethylisopsoralen and isobergapten.
These latter five compounds are active topically
at comparatively high concentration. Com-
pounds like psoralenquinone, 2-thiofurocoumarin,
5,8-dimethoxypsoralen (isopimpinellin), 5-nitro-
xanthotoxin, 5-aminoxanthotoxin, xanthotoxol
are inactive topically, as well as orally. All com-
pounds active topically, however, do not show
the same response when given orally. Dihydro-
xanthotoxin, 8-isoamyleneoxypsoralen, dimethyl-
isopsoralen, isobergapten, do not produce any
erythema even when given in large doses. On a
molar basis psoralen and methylated psoralen
derivatives possess high activity.
Furoehromone compounds represented by
khellin, chellol glucoside, and visnagin in Table
II do not exhibit any photodynamic response.
Compounds like furan, benzofuran have been
reported to be inactive (3). Furacin and the open
chain compound, einnamic acid, were found to be
inactive.
Coumarin compounds totaling 27 did not
exhibit any erythema inducing action except
thiocoumarin which showed some response at
very high concentration. It is evident from Table
III that coumarin and its other derivatives do
not possess the active configuration for photo-
dynamic action.
DISCUSSION
The furocoumarin ring configuration represents
a fused structure of furan and coumarin rings.
The unsubstituted psoralen molecule has been
shown to exhibit a photodynamic action in
presence of long wave ultraviolet (5). Photo-
dynamic action in mammalian skin in presence
of these compounds and ultraviolet light above
3200 A would be reflected by biological changes
of increased erythcma and pigmentation. By
topical application and oral feeding of different
furocoumarin, coumarin, furochromones and
other compounds to albino guinea pig and also
comparing the response on human skin, the rela-
tionship of molecular configuration to the ac-
tivity of various compounds has been evaluated.
The furan ring structure does not possess any
erythema inducing action. The coumarin ring
configuration compounds totaling 27 do not
show any photoactivation. Orally as well as
topically these different derivatives of coumarin
do not show any erythemal response. Even the
monomethyl, dimethyl and trimethyl derivatives
which presumably possess more electron density,
do not exhibit photodynamic effect. The psora-
len molecule which has a fused ring structure of
furan and coumarin shows highest activity. The
absorption spectra of this molecule reveals four
peaks of 212 mj.c, 254 mit, 294 mj.t and 320 mj.t.
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TABLE II
Relative activity of furochromones and other corn pounds
Compound Structure
Topical erythema
response (guinea
pig skin)
1. Khellin 0C113 Inactive 1000
I CIT3 sg./sq. in./O\ \/O\/
LQJ
OCH3
2. CheIlol glucoside (2-glucosoxy CH2—O—C5H1104 Inactive 1000
methyl-5-methoxy furochromone)
/O\/N1O\\/
jsg./sq. in.
flh
0CH3
3. Visnagin CIT3 Inactive 1000
g./sq. in.
0
OCH3
Other Compounds
1. Furan /O\ Inactive 1000jg./sq. in.
2. Benzofuran O\ \ Inactive 1000
g./sq. in.
3. Furacin (5-nitro-2-furaldehyde NH Inactive 1000
amino guanidine HC1) /O\ / eg./sq. in.
02N —CH=N.NHCHC1 \
NH2
4. Cinnamic acid 0 Inactive 1000/ g./sq. in.
C
INCII OH/CII
MOLECULAR CONFIGURATION OF FUROCOUMARINS 261
1. Coumarin
2
6 j
TABLE III
Relative activity of coumarin derivatives
2. 7-Hydroxycoumarin (umbelliferone)
3. 4-ilydroxycoumarin
4. 7-Hydroxy, 4-methylcoumarin (4-methylumbellifer-
one)
5. 3-Methyleoumarin
6. 4-Methylcoumarin
7. 6-Methyleoumarin
8. 7-Methyleoumarin
9. 5, 7-Dimethylcoumarin
10. 6, 7-Dimethylcoumarin
11. 4,5, 7-Trimethyleoumarin
12. 3-Ethyleoumarin
13. 3,4-Dihydro, 5-methyleoumarin
14. 3,4-Dihydro, 6-methyleoumarin
15. 3,4-Dihydro, 7-methyleoumarin
16. 3, 4-Dihydro, 6, 7-dimethylcoumarin
17. 5, 7-Dihydroxy, 4-methyleoumarin
18. 8-Isopropyl, 5-methyleoumarin
19. 4-Methyl, 7-ethoxyeoumarin
20. 2-Thioeoumarin
21. 3-Chloroeoumarin
22. 4 a Methylbenzocoumarin
23. 4 j3 Methylbenzocoumarin
24. Aeseuline (6,7-dihydroxy, 6-glucoside)
25. 7-Acetoxy, 4-methyleoumarin
7- (—O—-C—CH3)
0
26. 7-Allyloxycoumarin
7- (—O—CH2—CH2=C112)
27. /3 Methyl, napthyleoumarin
I3CH/
Though the action spectra and absorption spec-
tra for photodynamic activity of this molecule
have not been completely determined, character-
istic absorption of this compound in long wave
ultraviolet region can be said to be one of the
factors which makes this molecule photodynami-
cally active. Long wave ultraviolet does not
cause increased erythema and pigmentation, but
Comnnd
Activity (Erythemal response)
Topical effect
1000 g./sq to. Oral effect
No response 30 mg./kg.
No response 30 mg./kg.
No response 25 mg/kg.
No response 33 mg./kg.
No response 26.1 mg./kg.
No response 28.6 mg/kg.
No response 28.6 mg./kg.
No response 25.3 mg./kg.
No response 25 mg/kg.
No response 20 mg./kg.
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
+
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
Inactive
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in presence of this molecule, these biological
changes arc observed.
There are active sites in the psoralen molecule
which are favorable for photon induced activa-
tion. The active regions in psoralcn molecule arc
(a) valence bonds between carbon 3 and 4, (b)
carbon atoms 5 and 8, (c) intact lactonc ring,
(d) furan and coumarin rings fusion at carbon
atoms 6 and 7 to give linearly annulatcd struc-
ture of furocoumarin molecule, (c) unsaturated
linkage between carbon 4' and 5'.
Furochromonc molecule as studied in three of
its derivatives, has an altered 3-4 valence bond.
These compounds arc inactive. Fowlks (5) has
shown that open lactonc ring compound furo-
coumaric acid without any substitution at other
carbon atoms, is an inactive molecule.
Methyl radicals which arc known to increase
the electron density and carcinogenic activity in
carcinogenic compounds, however, do not appear
to increase the crythcma inducing property of
psoralcn on human skin. However, trimcthyl-
psoralen exhibits highest response in guinea pig
skin as compared to other active compounds.
Methyl substitution does not affect the active
centers in psoralen molecule by virtue of its
electron donating property.
Substitution with a methoxy group at carbon
5 or S results in decreased activity. 5, 8-Dimeth-
oxypsoralcn is completely inactive. Substitu-
tion with amino or nitro group at carbon 5 or
hydroxyl group at carbon 8 reveals the same effect
of inactivation. It appears that substitution with
methoxy, nitro, amino or hydroxy group results
in decreased electron density at carbon atoms 5
and 8 which therefore render the compound
inactive.
4'S'-dihydro, 8-methoxypsoralcn possesses very
low activity when applied topically and when
given orally does not show any photoreactiva-
tion. Methyl substitution at carbon 5' does not
alter the activity. The unsaturated linkage is
probably needed at these carbon atoms.
The linkage of furan ring with coumarin ring
at carbon 6 and 7 is essential. Furan ring attached
to carbon 7 and 8 as shown in isobergapten and
dimcthylisopsoralcn structure inactivates these
compounds.
It is thus evident that the linearly annulatcd
unsubstituted structure of furocoumarin molecule
possesses the maximum activity. Non-linear
structure loses its activity.
SUMMARY
Compounds of furocoumarin group which
induce crythcma and pigmentation of skin were
tested on albino guinea pig and human skin for
their relative activity along with other struc-
turally related coumarin, furochromone and
furan ring configuration compounds. A bioassay
method for screening active and inactive com-
pounds has been developed.
Of 17 furocoumarin compounds tested, psoralen
was found to be most active. A relationship of
molecular configuration to the activity of various
compounds is discussed. A linearly annulated,
unsubstituted compound baying fused furan and
coumarin rings, as present in psoralcn molecule
exhibits highest activity.
We are indebted for some of the compounds
used in this study to Dr. B. E. Christensen, Ore-
gon State College, Corvallis, Ore.; Paul B. Elder
Co., Bryan, Ohio; The Upjohn Co., Kalamazoo,
Mich.; Givaudin-Delawanna Inc., New York; S.
B. Pennick Co., New York; Sandoz Ltd., Basel,
Switzerland; Sunkist Growers, Corona, Calif.;
Trubek Laboratories, E. Rutherford, N. J.;
U.S.D.A. Fruit and Vegetable Research Labora-
tories, Pasadena, Calif.; and Van Ameringen
Haeblcr Inc., New York. We are grateful to Dr.
W. L. Fowlks for his interest and guidance in
this work.
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